RT Journal Article SR Electronic T1 Improving Risk Assessment JF Science Translational Medicine FD American Association for the Advancement of Science SP 159ps22 OP 159ps22 DO 10.1126/scitranslmed.3003497 VO 4 IS 159 A1 Dambach, Donna M. A1 Uppal, Hirdesh YR 2012 UL http://stm.sciencemag.org/content/4/159/159ps22.abstract AB Widespread sharing and analysis of clinical trial data and a U.S. government initiative to engineer nonclinical cell-based models that mimic human biological processes have the potential to improve predictions of drug-related adverse events.